Meir Medical Center Rheumatologic Biobank
Launched by MEIR MEDICAL CENTER · Mar 21, 2018
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
The Meir Medical Center Rheumatologic Biobank is a study aimed at understanding various autoimmune diseases like rheumatoid arthritis, lupus, and others. In this trial, researchers will collect samples such as blood, joint fluid, and skin tissue from patients who have these conditions. These samples will be stored in a biobank and used for future research to learn more about these diseases, but only after each study has been approved by an ethics board.
To participate, you need to be at least 18 years old, willing to provide consent, and have one of the rheumatoid conditions mentioned. There are no specific exclusions listed, so many people may qualify. If you join the trial, you can expect to provide some samples, which will help researchers gain valuable insights into these conditions and potentially improve treatments in the future. Your participation could make a difference in understanding and managing these diseases better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • above 18 years of age
- • willing to sign informed consent
- • have a rheumatoid condition
- Exclusion Criteria:
- • -
About Meir Medical Center
Meir Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a prominent sponsor of clinical studies, Meir Medical Center is committed to fostering collaboration among healthcare professionals, researchers, and patients to explore new therapies and treatment modalities. With a focus on ethical practices and patient safety, the center aims to contribute significantly to the scientific community while enhancing the quality of care provided to its diverse patient population. Through its robust infrastructure and multidisciplinary approach, Meir Medical Center stands at the forefront of medical innovation, driving progress in various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kfar Saba, Israel
Patients applied
Trial Officials
Yair Levy, Prof.
Principal Investigator
Meir Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials